Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer

Serum methylation levels ofTAC1. SEPT9andEYA4as diagnostic markers for early colorectal cancers: a pilot study

(2013) Yanqun Liu et al.   BIOMARKERS

Prognostic role of methylated free circulating DNA in colorectal cancer

(2012) Alexander B. Philipp et al.   INTERNATIONAL JOURNAL OF CANCER

Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer

(2011) Andreas Herbst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Surveillance After Colorectal Cancer Resection: A Systematic Review

(2011) Bilgi Baca et al.   DISEASES OF THE COLON & RECTUM

Diagnostic and Prognostic Value of Metastasis Inducer S100A4 Transcripts in Plasma of Colon, Rectal, and Gastric Cancer Patients

(2011) Ulrike Stein et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Intensive Risk-Adjusted Follow-up With the CEA, TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences

(2010) Andrea Nicolini   ARCHIVES OF SURGERY

Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: a systematic review

(2010) G Peach et al.   BRITISH JOURNAL OF CANCER

Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence

(2009) Andreas Herbst et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

(2009) Daniel Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 —a prognostic marker in colorectal cancer

(2008) Henriette Ytting et al.   HUMAN IMMUNOLOGY